Online Program Home
My Program

CC = Colorado Convention Center   H = Hyatt Regency Denver at Colorado Convention Center
* = applied session       ! = JSM meeting theme

Activity Details

55 * ! Sun, 7/28/2019, 4:00 PM - 5:50 PM CC-110
Recent Evaluations of Methods for Handling Noncompliance/Dropouts in Clinical Trials for Better Guidance Driven Application — Invited Papers
Biopharmaceutical Section
Organizer(s): Xiang Zhang, Eli Lilly and Company
Chair(s): Xiang Zhang, Eli Lilly and Company
4:05 PM Principal Component Causal Estimands for Equivalence Trials in the Presence of Intercurrent Events
Wanjie Sun, FDA
4:25 PM An Evaluation of the Trimmed Mean Approach in Clinical Trials with Dropout

Ming-Dauh Wang, Regeneron ; Craig Mallinckrodt, Biogen; Jiajun Liu, Biogen
4:45 PM Principal Stratification Approach for Bayesian Sequential Monitoring Design to Address Noncompliance in Clinical Trials
Weining Shen, University of California at Irvine
5:05 PM Test of Treatment Effect for Binary Composite Endpoint with Missing Components in Clinical Trials
Yanyao Yi, University of Wisconsin at Madison; Ting Ye, University of Wisconsin at Madison; Xiang Zhang, Eli Lilly and Company; Junxiang Luo, Sanofi-Aventis
5:25 PM Discussant: Ilya Lipkovich, Eli Lilly and Company
5:45 PM Floor Discussion